However, in MM cells PIs induce ISR/ATF4-driven expression of the pro-survival protein MCL1, and knockdown of ATF4 sensitizes MM cells to bortezomib, indicating a potential adaptive response triggered by bortezomib [87]. The gene discussed is MCL1; the disease is Miyoshi myopathy.